Global anti-rheumatics revenue of top pharmaceutical companies 2017 and 2024

The data displays the top ten pharmaceuticals companies worldwide based on anti-rheumatics revenue in 2017 and a projection for 2024. In 2017, Pfizer generated some six billion USD in anti-rheumatics revenue and is expected to generate around the same revenue by 2022. Anti-rheumatic drugs are used to treat and slow the progress of rheumatoid arthritis. Rheumatoid arthritis is an autoimmune disease that principally attacks the joints but also impacts tissues and organs.